Navigation Links
NIH awards UC $9 million grant to improve patient point-of-care technologies
Date:9/28/2007

A leading cause of disability in the United States is a neurological event such as stroke, head injury or drug abuse. Regardless of the cause, the brain is often quickly and irreversibly damaged. UC researchers, funded by a $9 million grant from the National Institutes of Health, will study point-of-care technologies to assist the diagnosis and treatment of patients with neurologic emergencies. The result is the "Point-of-Care Center for Emerging Neuro Technologies. This five-year award is renewable for five years.

It is estimated that one million brain cells die every minute during an ischemic stroke, says Fred Beyette, associate professor of electrical and computer engineering and principal investigator (PI) for the project. Its said that time is brain during a neurologic emergency. Point-of-care information is critical for preventing patient brain damage, dysfunction and death. Thus, there is a critical need for developing improved and rapid diagnostic information for the patient experiencing neurologic emergencies.

The UC center is dedicated to the development of technologies that will dramatically improve the care and health of the neurologic patient by providing fast and reliable information about the biological events occurring in this patient population, says Joseph Clark, professor of neurology in UCs College of Medicine and co-principal investigator (Co-PI) of the overall grant.

From Invention to Intervention

The focus of the Point-of-Care Center will be to nurture the development of technologies to improve the diagnosis of and response to neurodiseases and neurodisorders using point-of-care devices, whether at the bedside or in the operating room wherever diagnosis or treatment is needed, says Beyette. The NIH grant is intended to stimulate business in the community as well. The center will be structured to take ideas from conception to development of a prototype ready for clinical testing. Some of the factors that these new technologies will address include fast results in a package that is size-appropriate for the location.

For example, consider a patient with a persistent headache, lasting 18 to 20 hours. The patient has tried over-the-counter medications to no avail and is now experiencing nausea and visual impairment. Is it sinusitis" Migraine" Or perhaps a hemorrhagic stroke" Current technology takes hours to indicate the source of the problem. The improved point-of-care technologies could take a matter of one or two minutes. If the source is a migraine, then the patient would be referred to a general practitioner. If its meningitis, then a spinal tap is called for. However, if its an acute rupture of an artery in the brain, a CT scan is usually performed but is not effective after 12 hours following the event. A spinal tap would be called for but the information is often unreliable.

When a patient comes to an emergency room with a headache, blood and urine samples are routinely drawn. Spinal fluid tests are rarely used because of the minimal return on chemical information, says Clark. Current protocol would dictate sending the sample out for a biochemical assay, taking three to four hours. If the problem is a subarachnoid hemorrhage, its going to rupture again. But in doing the spinal tap, more blood might be introduced by the tap itself, making diagnosis difficult.

To address this, an instrument in development now is the size of a shoebox, into which the spinal fluid is introduced. Within three minutes, the instrument can distinguish hemoglobin and bilirubin (which indicates the breakdown of hemoglobin) from blood cells that might be present because of the procedure itself.

Beyette and Clark say that the center will be ramping up activities over the coming weeks and will soon be issuing a national call for proposals.

Winning this award speaks very highly of the quality of our team and the outstanding level of innovation that we are bringing to the diagnosis and treatment of neurologic-based diseases and disorders, says Beyette.


'/>"/>

Contact: Wendy Beckman
wendy.beckman@uc.edu
513-556-1826
University of Cincinnati
Source:Eurekalert

Related biology news :

1. A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020
2. UCLA launches $20 million stem cell institute to investigate HIV, cancer and neurological disorders
3. Six million Africans face famine because of locusts, drought
4. Retrovirus struck ancestors of chimpanzees and gorillas millions of years ago, but did not affect ancestral humans
5. Evidence of 600-million-year old fungi-algae symbiosis discovered in marine fossils
6. $5.1 billion would save 6 million children
7. Health costs soar as 60 million Americans classed as obese
8. Malaria killing a million a year
9. $6.5 Million Grant for Microarray Center at Yale School of Medicine
10. TGen awarded $7.1 million to accelerate brain disease research
11. MSU researchers receive $4 million grant to uncover gene functions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... BANGALORE, India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a ... ), and Onegini today announced a partnership to ... banking solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... banks to provide their customers enhanced security to ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... GUELPH, ON , June 27, 2016 /PRNewswire/ - BIOREM ... it has been advised by its major shareholders, Clean ... LP, United States based venture ... common shares of Biorem (on a fully diluted, as ... for the disposition of their entire equity holdings in ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... operations for Amgen, will join the faculty of the University of North ... adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of ... higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... of the cuvette holder. , FireflySci has developed several Agilent flow cell product ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
Breaking Biology Technology: